# Flare Capital Partners

> Flare Capital Partners is a VC fund backing Health Care and Medical. See 116 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 116
- Last investment: Jul 2026
- Lead investor: 35%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/6985683/
- X (Twitter): https://twitter.com/flarecapital
- Website: https://www.flarecapital.com/
- Facebook: https://www.facebook.com/FlareCapital

Flare Capital Partners is a VC fund in Boston focused on Health Care and Medical. Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies. The firm invests across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country.

## Contacts

5 contacts available for Flare Capital Partners. Shizune tracks 12 team members at Flare Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/flare-capitalpartners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.4M–$10M |
| Series A | $10M–$30M |
| Series B | $10M–$125M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 56 | 48% |
| Medical | 14 | 12% |
| Wellness | 11 | 9% |
| Hospital | 9 | 8% |
| Software | 8 | 7% |

62 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 25 | 22% |
| Seed | 22 | 19% |
| Series B | 17 | 15% |
| Series C | 14 | 12% |
| Series D | 7 | 6% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 56 | 48% |
| India | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Thomas Mac Mahon | Executive Partner | 2 | https://shizune.co/investors/profile/thomas-mac-mahon |
| Adam Bruce | Chief Financial Officer and Partner | 0 | https://shizune.co/investors/profile/adam-bruce-3 |
| Bill Geary | Executive Partner Advisor | 18 | https://shizune.co/investors/profile/bill-geary |
| Carter Prince | Flare Scholar | 1 | https://shizune.co/investors/profile/carter-prince |
| Chris Kryder | Executive Partner | 0 | https://shizune.co/investors/profile/chris-kryder |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inner Logic | Inner Logic serves as the development infrastructure for the next generation of procedural devices, including orthopedic implants, heart valves, and surgical robots. | $11.5M | Seed | Jul 22, 2026 |  |
| Upside | Upside is the only nationally scalable housing stability platform purpose-built for healthcare. The company partners with health plans and employers to identify and stabilize members and employees experiencing housing instability, connecting them to safe, supportive housing while reducing avoidable emergency utilization and improving healthoutcomes. Upside pairs dedicated Care Guides with AI-supported housing orchestration to deliver measurable results at scale. The platform serves Medicaid, Medicare Advantage, D-SNP, commercial, and employer-sponsored populations across the full housing continuum, from crisis intervention to long-term tenancy support. Founded in 2020 and headquartered in Fort Lauderdale, FL, Upside is redefining how healthcare addresses housing as a foundation of care. | $20M | Series A | Jun 25, 2026 |  |
| Photon | A modern prescription network | $16M | Series A | Apr 30, 2026 |  |
| Greatly Health | Greatly Health provides virtual integrative oncology programs for people living with and beyond cancer. The company offers access to integrative medicine approaches that are designed to complement conventional cancer care. Its services focus on areas such as exercise, nutrition, and mind-body practices delivered through an online platform. GreatlyHealth connects members with structured, evidence-informed programs that aim to help manage treatment side effects and support overall well-being. The platform serves patients, survivors, and caregivers seeking integrative support alongside their oncology care. Greatly Health does not itself deliver medical services and encourages users to maintain care with their existing clinical providers. | $4M | Seed | Apr 30, 2026 |  |
| Keebler Health | AI-Enabled Coding for Medical Billing Teams | $16M | Series A | Apr 15, 2026 |  |
| Qualified Health | Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $125M | Series B | Mar 25, 2026 |  |
| Daffodil Health | Daffodil Health is a paediatric behavioural health platform that offers multi-modal therapies and real-time support to special needs children and families. | $16.3M | Series A | Feb 17, 2026 |  |
| Atlas Oncology Partners | Atlas Oncology Partners operates a value-based oncology enablement platform for community oncology practices. The company embeds interdisciplinary care teams within oncology clinics to provide navigation, psychosocial and supportive care, symptom management, and cancer-adjacent condition management. It delivers whole-person, longitudinal cancercare through on-site and virtual services, including care coordination and advanced supportive care. Atlas assumes full medical cost risk from payers, negotiates outcomes-based contracts, and supplies analytics, technology, and capital to partner practices. | $28M | Series A | Feb 11, 2026 |  |
| Ethicos Health | Ethicos Health is a Nashville-based healthcare technology startup founded in 2023 with an AI-enabled platform designed to manage specialty pharmacy costs by tying medication coverage to real-world clinical effectiveness. The company's SaaS platform transforms traditional prior authorization by evaluating whether specialty medications areactually achieving their intended clinical endpoints for individual patients, enabling "fast-tracking" for effective therapies while allowing faster pivots for ineffective treatments. |  | Pre-Seed | Jan 07, 2026 |  |
| Greater Good Health | We aim to extend the reach of health plans, services offered through Medicare for seniors, and provider organizations in the communities they serve by enabling sophisticated value-based care programs that focus on quality improvement, and by creating access to high-quality senior primary care in markets that are struggling with physician shortages. | $20.5M | Series B | Dec 29, 2025 |  |

10 of 116 investments shown.

## Co-investors
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 14 deals together
- [Frist Cressey Ventures](https://shizune.co/investors/profile/frist-cresseyventures) — VC Fund, 14 deals together
- [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 11 deals together
- [Greycroft](https://shizune.co/investors/profile/greycroft) — VC Fund, 10 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 8 deals together
- [Town Hall Ventures](https://shizune.co/investors/profile/town-hall-ventures) — VC Fund, 8 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Health Care Investors in United States](https://shizune.co/investors/health-care-investors-united-states)
- [Health Care VC Funds in United States](https://shizune.co/investors/health-care-vc-funds-united-states)
- [Wellness Investors](https://shizune.co/investors/wellness-investors)
- [Wellness VC Funds](https://shizune.co/investors/wellness-vc-funds)
- [Wellness Investors in United States](https://shizune.co/investors/wellness-investors-united-states)

## FAQ

### What does Flare Capital Partners invest in?

Flare Capital Partners invests primarily in Health Care, Medical and Wellness startups, most often at Series A and Seed stage. Most of the 116 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Flare Capital Partners's check size?

Flare Capital Partners typically joins rounds of $2.4M–$10M at Seed, $10M–$30M at Series A and $10M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Flare Capital Partners participates in.

### How do I contact Flare Capital Partners?

Public channels for Flare Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Flare Capital Partners?

The team at Flare Capital Partners includes Thomas Mac Mahon (Executive Partner), Adam Bruce (Chief Financial Officer and Partner) and Bill Geary (Executive Partner Advisor), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co